Experts offer tips for treating, managing cardiac effects; using cardiac magnetic resonance imaging in patients chronic inflammatory conditions
Tom Collins is a freelance writer in South Florida, who has written about medical topics from nasty infections to ethical dilemmas, runaway tumors to tornado-chasing doctors. He travels the globe gathering conference health news and lives in West Palm Beach.
Articles by Thomas R. Collins
EULAR 2014: Non-Tumor Necrosis Factor Biologics Update
Clinical trials on rheumatology drugs, including sarilumab, show promise for patients with rheumatoid arthritis also taking methotrexate
EULAR 2014: Biosimilar Drug Production Raises Concerns
Rheumatology experts question biosimilars’ safety, efficacy given their complex production process
EULAR 2014: Research on Rheumatoid Arthritis, Spondyloarthritis
Latest findings on rheumatological drug therapies, including methotrexate for RA, tumor necrosis factor inhibitors for SpA
How the Idea of Autoimmunity Emerged
A rheumatologist at the ACR’s State-of-the-Art Clinical Symposium in Chicago recalls history of immunology, urges scientists to further explore relationship between autoimmunity, microbiomes
What’s New in Inflammatory Arthritis?
Rheumatology experts at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss latest drug therapies, insights into axial spondyloarthritis and bone erosion, repair
New Osteoporosis Drugs Show Promise in Therapy Pipeline
Rheumatologists at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss medication alternatives to bisphosphonates that reduce bone resorption, build bone density and may provide new treatment options
Expansion of Mobile Health Apps Makes Physicians’ Job Easier
Rheumatologists choose, review top mobile health devices
Tech Talk: Physicians Debate Using Cell Phones to Communicate with Patients
Concerns about protecting personal privacy and receiving after-hours calls are balanced by physicians’ desire to connect with patients
EULAR 2013: New RA Recommendations Address Combination Therapy Concerns
Guidelines give greater nod to use of combination conventional disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis, leave monotherapy with methotrexate as acceptable first-line treatment
- « Previous Page
- 1
- …
- 24
- 25
- 26
- 27
- 28
- …
- 31
- Next Page »